Bellerophon Therapeutics (BLPH) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts BLPH Hot Sheet
Join SI Premium – FREE
Bellerophon Therapeutics (NASDAQ: BLPH) reported Q2 EPS of ($0.39), $0.12 better than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- Airbnb Inc. (ABNB) PT Raised to $175 at Jefferies
- Morgan Stanley Downgrades Tryg A/S (TRYG:DC) (TGVSF) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
